Bioaegis Therapeutics Inc.

Morristown, NJ

UEI
G2AZAC2PG7X3
CAGE
6QA91
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
6 E Cove Ln, Morristown, NJ 07960, USA
Website
bioaegistherapeutics.com
Founded
2011
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Bioaegis Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Bioaegis: plasma gelsolin (pgsn), an abundant, circulating protein modulates inflammation while also enhancing host… Contract · 75A50123C00067 Office of the Assistant Secretary for Preparedness and Response $20,000,000
Develop a safe and effective therapeutic to mitigate severe outcomes, including but not limited to mortality, in… Contract · 75A50121C00060 Office of the Assistant Secretary for Preparedness and Response $749,000

Quick answers

What is Bioaegis Therapeutics Inc.'s UEI?

Bioaegis Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is G2AZAC2PG7X3.

What is Bioaegis Therapeutics Inc.'s CAGE code?

Bioaegis Therapeutics Inc.'s CAGE code is 6QA91.

What is Bioaegis Therapeutics Inc.'s primary NAICS code?

Bioaegis Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Bioaegis Therapeutics Inc. located?

Bioaegis Therapeutics Inc.'s physical address in SAM.gov is 6 E Cove Ln, Morristown, NJ 07960, USA.

Is Bioaegis Therapeutics Inc. registered in SAM.gov?

Yes. Bioaegis Therapeutics Inc.'s SAM.gov registration is active through December 30, 2026.

What is Bioaegis Therapeutics Inc.'s most recent federal award?

Bioaegis Therapeutics Inc.'s most recent federal contract award is Bioaegis: plasma gelsolin (pgsn), an abundant, circulating protein modulates inflammation while also enhancing host… (75A50123C00067), from Office of the Assistant Secretary for Preparedness and Response, on September 21, 2023.

On GovTribe

See Bioaegis Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login